Search

everythinglearnresearchcommunity

for

Search:↓

Gabapentin may help relieve itchy scalp in lichen planopilaris patients.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.

Yellow dots look different in various hair loss conditions and can help diagnose them.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

A young man developed a rare, bilateral scalp condition after head trauma, causing hair loss but no neurological or eye issues.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Low-dose oral minoxidil helped regrow eyebrows in women with Frontal Fibrosing Alopecia.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

FFA's causes may include environmental triggers and genetic factors.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.